Who owns Immunome Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of IMNM from SEC Form 13F filings across 211 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 211 institutions disclosed 119.9M shares of Immunome Inc. worth $2.58B — about 105.6% of shares outstanding; the largest disclosed holder is T. Rowe Price Investment Management, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
211
13F holders
$2.58B
value, 2026 filers
105.6%
of shares outstanding (119.9M sh)
33
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of IMNM's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | T. Rowe Price Investment Management, Inc. | 20.2M | $434.7M | 0.3% | 17.8% | +2.7% |
| 2 | FMR LLC | 17.0M | $366.5M | 0.0% | 15% | +0.3% |
| 3 | BlackRock, Inc. | 8.9M | $192.1M | 0.0% | 7.9% | +1.4% |
| 4 | WELLINGTON MANAGEMENT GROUP LLP | 6.0M | $129.9M | 0.0% | 5.3% | +16.0% |
| 5 | Driehaus Capital Management LLC | 5.0M | $107.1M | 0.7% | 4.4% | +14.5% |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | 4.9M | $105.0M | 0.0% | 4.3% | +7.3% |
| 7 | PRIMECAP MANAGEMENT CO/CA/ | 4.6M | $99.9M | 0.1% | 4.1% | +1.4% |
| 8 | STATE STREET CORP | 4.5M | $96.6M | 0.0% | 4% | -18.3% |
| 9 | Redmile Group, LLC | 4.4M | $93.8M | 6.9% | 3.8% | -11.2% |
| 10 | ENAVATE SCIENCES GP, LLC | 3.6M | $77.7M | 27.8% | 3.2% | 0.0% |
| 11 | GEODE CAPITAL MANAGEMENT, LLC | 2.8M | $60.6M | 0.0% | 2.5% | +2.2% |
| 12 | Hood River Capital Management LLCNEW | 2.7M | $57.9M | 0.5% | 2.4% | new |
| 13 | SILVERARC CAPITAL MANAGEMENT, LLC | 2.1M | $45.0M | 5.3% | 1.8% | +3.8% |
| 14 | MORGAN STANLEY | 1.7M | $36.3M | 0.0% | 1.5% | -29.9% |
| 15 | Sofinnova Investments, Inc. | 1.6M | $35.0M | 1.5% | 1.4% | -5.4% |
| 16 | JPMORGAN CHASE & CO | 1.6M | $34.2M | 0.0% | 1.4% | -15.8% |
| 17 | GOLDMAN SACHS GROUP INC | 1.4M | $30.8M | 0.0% | 1.3% | -5.5% |
| 18 | PRICE T ROWE ASSOCIATES INC /MD/ | 1.3M | $28.8M | 0.0% | 1.2% | -24.5% |
| 19 | VANGUARD PORTFOLIO MANAGEMENT LLC | 1.3M | $27.9M | 0.0% | 1.1% | -3.9% |
| 20 | PRINCIPAL FINANCIAL GROUP INC | 1.2M | $25.9M | 0.0% | 1.1% | -10.5% |
| 21 | READYSTATE ASSET MANAGEMENT LP | 1.1M | $23.5M | 0.7% | 1% | -32.0% |
| 22 | BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 1.1M | $23.4M | 0.0% | 1% | -13.0% |
| 23 | Woodline Partners LP | 1.0M | $21.5M | 0.1% | 0.9% | 0.0% |
| 24 | NORTHERN TRUST CORP | 998,337 | $21.5M | 0.0% | 0.9% | +3.1% |
| 25 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 996,742 | $21.4M | 0.0% | 0.9% | +12.5% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.